Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation

Annals of Emergency Medicine

Volumn 29, Issue 1, 1997, Pages 126-134

  Innes, G D ^a   Vertesi, L ^a   Dillon, E C ^a   Metcalfe, C ^a  

^a ROYAL COLUMBIAN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; QUINIDINE; VERAPAMIL;

ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITALIZATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; TREATMENT OUTCOME; VOMITING;

EID: 0031016603     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-0644(97)70318-4     Document Type: Article

References (43)

1. HZ Friedman SF Goldberg JD Bonema Acute complications associated with new-onset atrial fibrillation Am J Cardiol 67 1991 437 439
2. RH Falk AA Knowlton SA Bernard Digoxin for converting recent onset atrial fibrillation to sinus rhythm Ann Intern Med 106 1987 503 506
3. SA Roberts C Diaz PE Nolan Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter Am J Cardiol 72 1993 567 573
4. ELC Pritchett Management of atrial fibrillation N Engl J Med 326 1992 1264 1270
5. JM Rawles MJ Metcalfe K Jennings Time of occurrence, duration, and ventricular rate of PAF Br Heart J 63 1990 225 227
6. BH Sarter FE Marchlinski Redefining the role of digoxin in the treatment of atrial fibrillation Am J Cardiol 69 1992 71G 81G
7. JI Haft MA Habbab Treatment of atrial arrhythmias: Effectiveness of verapamil when preceded by calcium infusion Arch Intern Med 146 1986 1085 1089
8. BE Haynes JT Niemann KS Haynes Supraventricular tachyarrhythmias and rate-related hypotension: Cardiovascular effects and efficacy of intravenous verapamil Ann Emerg Med 19 1990 861 864
9. WS Aronow D Landa G Plasencia Verapamil in atrial fibrillation and flutter Clin Pharmacol Ther 26 1979 578 582
10. C Tommaso T McDonough M Parker Atrial fibrillation and flutter: Immediate control with intravenously administered verapamil Arch Intern Med 143 1983 877 881
11. HO Klein R Ninio V Oren Acute hemodynamic effects of intravenous verapamil in patients with coronary artery disease Circulation 67 1983 101 109
12. HO Klein E Kaplinsky Digitalis and verapamil in atrial fibrillation and flutter Drugs 31 1986 185 197
13. SE Coplen EM Antman JA Berlin Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion Circulation 82 1990 1106 1115
14. M Zehender S Hohnloser B Muller Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: Results of a comparative study and a 2 year follow-up J Am Coll Cardiol 19 1992 1054 1059
15. A Borgeat JJ Goy R Maendly Flecainide vs quinidine for conversion of atrial fibrillation to sinus rhythm Am J Cardiol 58 1986 496 498
16. AZ Arnold MJ Mick RP Mazurek Role of prophylactic anticoagulation for DC cardioversion in patients with atrial fibrillation or flutter J Am Coll Cardiol 19 1992 851 855
17. American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiac care: Verapamil JAMA 268 1992 2207
18. UR Shettigar JG Toole DO Appun Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter Am Heart J 126 1993 368 374
19. SC Reimold CO Cantillon PL Friedman Propafenone vs sotalol for suppression of recurrent symptomatic atrial fibrillation Am J Cardiol 71 1993 558 563
20. MH Hwang J Danoviz I Pacold Double-blind crossover randomized trial of intravenously administered verapamil Arch Intern Med 144 1984 491 494
21. DM Salerno VC Dias RE Kleiger Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and flutter Am J Cardiol 63 1989 1046 1051
22. SJ Connolly DL Hoffert Usefulness of propafenone for recurrent paroxysmal atrial fibrillation Am J Cardiol 63 1989 817 819
23. The Esmolol Versus Placebo Multicenter Study Group Comparison of the efficacy and safety of esmolol, a short acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias Am Heart J 111 1986 42 48
24. PE Fenster KA Comess R Marsh Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion Am Heart J 106 1983 501 504
25. M Schwartz EL Michelson HS Sawin Esmolol: Safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythymias Chest 93 1988 705 711
26. E Hjelms Procainamide conversion of acute atrial fibrillation after open heart surgery compared with digoxin treatment Scand J Thorac Cardiovasc Surg 26 1992 193 196
27. KD Donovan GJ Dobb LJ Coombs Efficacy of flecainide for the reversion of acute onset atrial fibrillation Am J Cardiol 70 1992 50A 54A
28. MJ Suttorp JH Kingma ER Jessurun The value of class 1C antiarrhythmics for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm J Am Coll Cardiol 16 1990 1722 1727
29. JH Kingma MJ Suttorp Acute pharmacologic conversion of atrial fibrillation and flutter: The role of flecainide, propafenone, and verapamil Am J Cardiol 70 1992 56A 60A
30. A Capucci T Lenzi G Boriani Effectiveness of loading oral flecainide for converting recent onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension Am J Cardiol 70 1992 69 72
31. M Noc D Stajer M Horvat Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm Am J Cardiol 65 1990 679 680
32. AH Madrid C Moro E Marin-Huerta Comparison of flecainide and procainamide in cardioversion of atrial fibrillation Eur Heart J 14 1993 1127 1131
33. A Roth E Kaluski S Felner Clonidine for patients with rapid atrial fibrillation Ann Intern Med 116 1992 388 390
34. EV Platia EL Michelson JK Porterfield Esmolol versus verapamil in the acute treatment of atrial fibrillation or flutter Am J Cardiol 63 1989 925 929
35. KA Ellenbogen VC Dias VJ Plumb A placebo-controlled trial of continuous intravenous diltiazem infusion for 24 hour heart rate control during atrial fibrillation and flutter J Am Coll Cardiol 18 1991 891 897
36. SH Hohnloser M Zabel Short and long term efficacy and safety of flecainide acetate for supraventricular arrhythmias Am J Cardiol 70 1992 3A 10A
37. GK Feld PS Chen P Nicod Possible atrial proarrhythmic effects of class 1C antiarrhythmics Am J Cardiol 66 1990 378 383
38. SM Pai V Torres Atrial fibrillation: New management strategies Curr Probl Cardiol 18 1993 233 300
39. DS Echt PR Liebson LB Mitchell Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 1991 781 788
40. DJ Macneil RO Davies D Deitchman Clinical safety profile of sotalol in the treatment of arrhythmias Am J Cardiol 72 1993 44A 50A
41. LF Soyka C Wirtz RB Spangenberg Clinical safety profile of sotalol in patients with arrhythmias Am J Cardiol 65 1990 82A 83A
42. JT Hii DG Wyse AM Gillis Propafenone-induced torsades de pointes: Cross reactivity with quinidine Pacing Clin Electrophysiol 14 1991 1568 1570
43. TS Faber M Zehender A Van de Loo Torsades de pointes complicating drug treatment of low-malignant forms of arrhythmias: Four case reports Clin Cardiol 17 1994 197 202